The antidepressants and sexual dysfunction: a pharmacovigilance-pharmacodynamic study of the FDA adverse event reporting system
The present investigation has detected new and unexpected signals of antidepressant-related SDs. Further research is needed to validate and clarify the observed associations.
Authors
- Qingqing Xu (ORCID: https://orcid.org/0000-0002-7703-5872)
- Shunying Yu (ORCID: https://orcid.org/0000-0001-7929-204X)
- Fan Mou
- Cheng Yu
- Wanying Wang (ORCID: https://orcid.org/0009-0001-9973-5466)
- Yingting Tan
- Ruiyi Qian (ORCID: https://orcid.org/0009-0006-9460-6530)
- Youjun Chen
- Xue Zhao
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai Mental Health Center (CN)
- Shanghai Ninth People's Hospital (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1080/14740338.2024.2443956
- Citations
- 4
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- Fundamental Research Funds for the Central Universities